Biodistribution properties of nanoparticles based on mixtures of PLGA with PLGA-PEG diblock copolymers

International Journal of Pharmaceutics

Volumn 298, Issue 1, 2005, Pages 233-241

  Beletsi, A ^a   Panagi, Z ^a   Avgoustakis, K ^a  

^a UNIVERSITY OF PATRAS   (Greece)

Author keywords

Biodistribution; Physicochemical characteristics; Poly(lactide co glycolide) poly(lactide co glycolide) poly(ethylene glycol) nanoparticles

Indexed keywords

COPOLYMER; MACROGOL; NANOPARTICLE; POLYGLACTIN;

ARTICLE; BLOOD; PARTICLE SIZE; PRIORITY JOURNAL;

ANIMALS; FEMALE; LACTIC ACID; MICE; NANOSTRUCTURES; POLYETHYLENE GLYCOLS; POLYGLACTIN 910; POLYGLYCOLIC ACID; POLYMERS; TISSUE DISTRIBUTION;

EID: 20444467972     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2005.03.024     Document Type: Article

References (21)

1. K. Avgoustakis Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery Curr. Drug Deliv. 1 2004 321 333
2. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, A.G. Karydas, and D.S. Ithakissios PLGA-mPEG nanoparticles of cisplatin: in vitro nanoparticle degradation in vitro drug release in vivo drug residence in blood properties J. Control. Release 79 2002 123 135
3. K. Avgoustakis, A. Beletsi, Z. Panagi, P. Klepetsanis, E. Livaniou, G. Evangelatos, and D.S. Ithakissios Effect of copolymer composition on the physicochemical characteristics, in vitro stability, and biodistribution of PLGA-mPEG nanoparticles Int. J. Pharm. 259 2003 115 127
4. D. Bazile, C. Prud'Homme, M.T. Bassoullet, M. Marlard, G. Spenlehauer, and M. Veillard Stealth Me.PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system J. Pharm. Sci. 84 1995 493 498
5. A. Beletsi, L. Leondiadis, P. Klepetsanis, D.S. Ithakissios, and K. Avgoustakis Effect of preparative variables on the properties of PLGA-mPEG copolymers related to their application in controlled drug delivery Int. J. Pharm. 182 1999 187 197
6. S.S. Davis, and L. Illum Particulate systems for site specific drug delivery G. Gregoriadis B. McCormack G. Poste Targeting of Drugs 4: Advances in System Constructs, NATO ASI Series 1994 Plenum Press New York 183 194
7. F. De Jaeghere, E. Allemann, J.C. Leroux, W. Stevels, J. Feijen, E. Doelker, and R. Gurny Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake Pharm. Res. 16 1999 859 866
8. T. Gorner, R. Gref, D. Michenot, F. Sommer, M.N. Tran, and E. Dellacherie Lidocaine-loaded biodegradable nanospheres. I. Optimization of the drug incorporation into the polymer matrix J. Control. Release 57 1999 259 268
9. R. Gref, A. Domb, P. Quellec, T. Blunk, R.H. Muller, J.M. Verbavatz, and R. Langer The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres Adv. Drug Deliv. Rev. 16 1995 215 223
10. R. Gref, M. Luck, P. Quellec, E. Marchand, E. Dellacherie, S. Harnisch, T. Blunk, and R.H. Muller 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol(PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption Colloids Surf. B: Biointerfaces 18 2000 301 313
11. R. Gref, Y. Minamitake, M.T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer Biodegradable long-circulating polymeric nanospheres Science 263 1994 1600 1603
12. V.C.F. Mosqueira, P. Lengrand, J.-L. Morgat, M. Vert, E. Mysiakine, R. Gref, J.-P. Devissaguet, and G. Barratt Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density Pharm. Res. 18 2001 1411 1419
13. Z. Panagi, A. Beletsi, G. Evangelatos, E. Livaniou, D.S. Ithakissios, and K. Avgoustakis Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles Int. J. Pharm. 221 2001 143 152
14. M.T. Peracchia Stealth nanoparticles for intravenous administration S.T.P. Pharma Sci. 13 2003 155 161
15. M.T. Peracchia, E. Fattal, D. Desmaele, M. Besnard, J.P. Noel, J.M. Gomis, M. Appel, J. d'Angelo, and P. Couvreur Stealth PEGylated nanoparticles for intravenous administration and splenic targeting J. Control. Release 60 1999 121 128
16. P. Quellec, R. Gref, L. Perrin, E. Dellacherie, F. Sommer, J.M. Verbavatz, and M.J. Alonso Protein encapsulation within polyethylene glycol-coated nanospheres. I. Physicochemical characterization J. Biomed. Mater. Res. 42 1998 45 54
17. G.E.C. Sims, and T.J. Snape A method for the estimation of polyethylene glycol in plasma protein fractions Anal. Biochem. 107 1980 60 63
18. S. Stolnik, S.E. Dunn, M.C. Garnett, M.C. Davies, A.G.A. Coombes, D.C. Taylor, M.P. Irving, S.C. Purkiss, T.F. Tadros, S.S. Davis, and L. Illum Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethyleneglycol) copolymers Pharm. Res. 11 1994 1800 1808
19. S. Stolnik, C.R. Heald, J. Neal, M.C. Garnett, S.S. Davis, L. Illum, S.C. Purkis, R.J. Barlow, and P.R. Gellert Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance J. Drug Target. 9 2001 361 378
20. M.F. Zambaux, F. Bonneaux, R. Gref, E. Dellacherie, and C. Vigneron MPEO-PLA nanoparticles: effect of MPEO content on some of their surface properties J. Biomed. Mater. Res. 44 1999 109 115
21. M.F. Zambaux, B. Faivre-Fiorina, F. Bonneaux, S. Marchal, J.L. Merlin, E. Dellacherie, P. Labrude, and C. Vigneron Involvement of neutrophilic granulocytes in the uptake of biodegradable non-stealth and stealth nanoparticles in guinea pig Biomaterials 21 2000 975 980